logo

Aquestive Therapeutics Inc. (AQST)



Trade AQST now with
  Date
  Headline
2/9/2021 7:43:40 AM Aquestive Adds Julie Krop, Marco Taglietti To Board; Douglas Bratton Resigns From Board
1/21/2021 8:39:48 AM Mitsubishi And Aquestive Announce U.S. Licensing And Supply Deal For Riluzole Oral Film For ALS Treatment
8/20/2020 7:35:38 AM Aquestive Therapeutics Initiates Phase 1 Pharmacokinetic Trial Of AQST-108 For Allergic Reactions Incl Anaphylaxis
6/29/2020 7:25:07 AM Aquestive Therapeutics Submits IND For Pharmacokinetic Clinical Trials Of AQST-108 For Anaphylaxis Treatment
1/12/2020 8:03:08 PM Aquestive Therapeutics Gets FDA Response To Citizen’s Petition
1/10/2020 6:36:07 AM Aquestive Therapeutics Sees Q4 Preliminary Total Revenues To Be $16 Mln; Issues 2020 Revenues View Of $35 Mln-$45 Mln
3/18/2019 6:31:52 AM Wedbush Is Lowering Aquestive Therapeutics Inc. (AQST) FY19 Rev. Estimate To 44.5 M From 57.4 M
3/18/2019 6:31:35 AM Wedbush Is Cutting Aquestive Therapeutics Inc. (AQST) Q4 19 Rev. Estimate To 10.6 M From 11.8 M
3/18/2019 6:31:18 AM Wedbush Is Lowering Aquestive Therapeutics Inc. (AQST) Q3 19 Rev. Estimate To 10.2 M From 19.3 M
3/18/2019 6:31:05 AM Wedbush Is Raising Aquestive Therapeutics Inc. (AQST) Q2 19 Rev. Estimate To 11.2 M From 11.0 M
3/18/2019 6:30:51 AM Wedbush Is Cutting Aquestive Therapeutics Inc. (AQST) Q1 19 Rev. Estimate To 12.6 M From 15.4 M
3/18/2019 6:30:26 AM Wedbush Is Raising Aquestive Therapeutics Inc. (AQST) FY19 Estimate To -1.91 From -3.19
3/18/2019 6:30:04 AM Wedbush Is Increasing Aquestive Therapeutics Inc. (AQST) Q4 19 Estimate To -0.42 From -1.08
3/18/2019 6:29:44 AM Wedbush Is Increasing Aquestive Therapeutics Inc. (AQST) Q3 19 Estimate To -0.49 From -0.76